Stein, E. M. (2018). The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationStein, E. M. The DOT1L Inhibitor Pinometostat Reduces H3K79 Methylation and Has Modest Clinical Activity in Adult Acute Leukemia. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationStein, E. M. The DOT1L Inhibitor Pinometostat Reduces H3K79 Methylation and Has Modest Clinical Activity in Adult Acute Leukemia. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.